![Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases](https://f6publishing.blob.core.windows.net/964c63b6-3412-4e90-86e6-ee59b6115d73/WJH-12-533-g001.png)
Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases
![Frontiers | Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines Frontiers | Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines](https://www.frontiersin.org/files/Articles/1042442/fnins-16-1042442-HTML-r1/image_m/fnins-16-1042442-g001.jpg)
Frontiers | Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
![Management of Nonalcoholic Fatty Liver Disease: Lessons Learned From Type 2 Diabetes - Texas Liver Institute Management of Nonalcoholic Fatty Liver Disease: Lessons Learned From Type 2 Diabetes - Texas Liver Institute](https://txliver.com/wp-content/uploads/2018/11/Stages-of-Liver-Damage.png)
Management of Nonalcoholic Fatty Liver Disease: Lessons Learned From Type 2 Diabetes - Texas Liver Institute
![Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus | Nature Reviews Endocrinology Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrendo.2017.173/MediaObjects/41574_2018_Article_BFnrendo2017173_Fig1_HTML.jpg)
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus | Nature Reviews Endocrinology
![Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives](https://f6publishing.blob.core.windows.net/b3cd08fe-1fff-4e05-afaf-f56860eed7cf/WJG-28-775-g001.png)
Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives
![Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/1b5e0dc9-6c0b-49ef-99f8-9d1edd76ded4/gr1.jpg)
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology
![Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes - Hydes - 2020 - Diabetic Medicine - Wiley Online Library Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes - Hydes - 2020 - Diabetic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4bc47c32-078c-4c53-84c1-2cefda4d2f60/dme14356-fig-0002-m.jpg)
Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes - Hydes - 2020 - Diabetic Medicine - Wiley Online Library
![Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease | SpringerLink Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11892-020-01349-1/MediaObjects/11892_2020_1349_Fig1_HTML.png)
Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease | SpringerLink
![Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus - NASH pipeline, phase 3 Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus - NASH pipeline, phase 3](https://www.natap.org/2022/images/060622/060622-5/0606221.gif)
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus - NASH pipeline, phase 3
![Assessment and Treatment of Non-alcoholic Fatty Liver Disease in Type 2... | Download Scientific Diagram Assessment and Treatment of Non-alcoholic Fatty Liver Disease in Type 2... | Download Scientific Diagram](https://www.researchgate.net/publication/351490459/figure/fig1/AS:1022264468312068@1620738250424/Assessment-and-Treatment-of-Non-alcoholic-Fatty-Liver-Disease-in-Type-2-Diabetes-ACE.jpg)
Assessment and Treatment of Non-alcoholic Fatty Liver Disease in Type 2... | Download Scientific Diagram
![Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? | Clinical Diabetes and Endocrinology | Full Text Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? | Clinical Diabetes and Endocrinology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40842-020-00097-1/MediaObjects/40842_2020_97_Fig2_HTML.png)
Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? | Clinical Diabetes and Endocrinology | Full Text
![Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development](https://pub.mdpi-res.com/nutrients/nutrients-13-01442/article_deploy/html/images/nutrients-13-01442-g001.png?1619256508)
Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development
![Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases - The Lancet Gastroenterology & Hepatology Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/c550a8c8-13d4-4ac2-b258-87fb3c8ffe35/gr1_lrg.jpg)
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases - The Lancet Gastroenterology & Hepatology
![Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? - ScienceDirect Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1590865816308684-gr1.jpg)
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? - ScienceDirect
![IJMS | Free Full-Text | Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment IJMS | Free Full-Text | Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment](https://pub.mdpi-res.com/ijms/ijms-23-15489/article_deploy/html/images/ijms-23-15489-g001.png?1670411940)
IJMS | Free Full-Text | Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
![Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach - The Lancet Gastroenterology & Hepatology Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/65646d01-322a-4ab3-bde9-4a5f09044e13/gr1.jpg)